Medifast, Inc.
A maker of meal-replacement and metabolic-health products, Medifast sells its foods and coach-guided programs under the Optavia and Trilivy brands, used by people looking to manage their weight and metabolic health. It was founded in 1980 by Dr. William Vitale, a Baltimore dermatologist who started mixing his own liquid-diet formula after struggling to source products from other providers. The name is a blend of "medical" and "fast," a nod to the medically supervised, quick weight loss the company was built around.
Granted 19.3K · Bought 76.8K
Granted 41.8K · Bought 17.7K
Granted 11.7K · Bought 5.0K
Granted 35.4K
Granted 11.7K
Granted 11.7K
Granted 10.8K
Granted 18.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kiai ParsaDirector · 8 transactions | — | 688.4K | 19.3K | 76.8K | — |
| Chard Daniel RChairman & CEO, Director · 6 transactions | +25.4% | 483.0K | 41.8K | 17.7K | — |
| Schlackman ScottDirector · 3 transactions | +65.3% | 42.2K | 11.7K | 5.0K | — |
| Maloney James P.Chief Financial Officer · 5 transactions | -10.9% | 37.7K | 35.4K | — | — |
| Thomas Andrea BDirector · 1 transaction | +48.6% | 35.7K | 11.7K | — | — |
| Geary Elizabeth A.Director · 1 transaction | +59.8% | 31.2K | 11.7K | — | — |
| MacKenzie Jonathan BarrettVP, Finance & CAO · 4 transactions | +87.1% | 20.8K | 10.8K | — | — |
| Rose Jeffrey MatthewDirector · 2 transactions | — | 11.7K | 18.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: +99.5K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.